News

24 September 2024

BAP Pharma Recipient of MSDUK High Growth Business of the Year award

BAP Pharma are the honoured recipients of the High Growth Business of the Year award, presented at the MSDUK and ESDP Business Connect 2024 Awards.

The MSDUK & ESDP Business Connect event provided a valuable platform for connecting with inspiring ethnic minority entrepreneurs and industry experts and engaging in dynamic discussions to share innovative insights and explore the latest trends in Supplier Diversity.

The Minority Supplier Development UK (MSDUK) is the UK’s premier not-for-profit membership organisation, championing diversity and inclusion in the public and private sector supply chains.

BAP Pharma are proud to be certified as an Ethnic Minority Business by the MSDUK. Equality and diversity are ingrained into our company ethos and are reflected both in the work we do and in the way we source diverse suppliers.

We would also like to congratulate all the MSDUK & ESDP Business Awards nominees and winners.

“We are very honoured to receive the High Growth Business of the Year Award from the prestigious MSDUK & ESDP organisations in recognition of our extraordinary success and growth. MSDUK & ESDP are committed to breaking down the barriers and inequalities faced by ethnic minority businesses (EMBs) in supply chains by uniting pioneering and fast-growing ethnic minority businesses with global corporations that are dedicated to creating a diverse and inclusive supply chain.

Our consistent growth has been fuelled by new customer acquisition, diversification of our offerings, and global expansion into new markets, all of which have resulted in the formation of two new divisions and a move into new, larger facilities with a broader range of capabilities.

Throughout this journey, we have maintained an unwavering focus on promoting diversity, both within our organisation and externally, with our suppliers, enabling us to continue to deliver on our promises and provide clients and patients with customer service excellence.”

Dr. Bashir Parkar, Founder and Managing Director of BAP Pharma.

You Might Also Like

BAP Pharma Hosts Grand Opening Ceremony for its New US Headquarters

SOMERSET N.J. (BUSINESS WIRE) On Wednesday 24th April 2024 BAP Pharma hosted the Grand Opening Ceremony for its new US headquarters in Somerset NJ. The weather could not have been better for an exciting day of events as BAP Pharma welcomed guests and dignitaries to the Grand Opening Ceremony of

BAP Pharma Hosts Grand Opening Ceremony for its New US Headquarters

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

BAP Pharma Limited is pleased to announce the signing of an exclusive agreement for the supply and distribution of Bicillin® L-A (Penicillin G Benzathine) to expand access to the product in the UK and Europe (previously only available in the US)   Product Details Bicillin® L-A is a ready-to-use Benzathine

Exclusive Agreement For The Supply and Distribution Of Bicillin® LA

BAP Pharma Appointed An Export Champion

BAP Pharma are proud to announce that our UK General Manager – Rebecca Bibby – has been appointed an Export Champion for the Southeast, by the Department for Business and Trade (DBT) and has been invited to join the Export Champions programme – a vital element of the UK Government’s

BAP Pharma Appointed An Export Champion